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Background: The sequenced O45:K1:H7 Escherichia coli meningitis strain S88 harbors a large virulence plasmid. To
identify possible genetic determinants of pS88 virulence, we examined the transcriptomes of 88 plasmidic ORFs
corresponding to known and putative virulence genes, and 35 ORFs of unknown function.
Results: Quantification of plasmidic transcripts was obtained by quantitative real-time reverse transcription of
extracted RNA, normalized on three housekeeping genes. The transcriptome of E. coli strain S88 grown in human
serum and urine ex vivo were compared to that obtained during growth in Luria Bertani broth, with and without
iron depletion. We also analyzed the transcriptome of a pS88-like plasmid recovered from a neonate with urinary
tract infection. The transcriptome obtained after ex vivo growth in serum and urine was very similar to those
obtained in iron-depleted LB broth. Genes encoding iron acquisition systems were strongly upregulated. ShiF
and ORF 123, two ORFs encoding protein with hypothetical function and physically linked to aerobactin and
salmochelin loci, respectively, were also highly expressed in iron-depleted conditions and may correspond to
ancillary iron acquisition genes. Four ORFs were induced ex vivo, independently of the iron concentration.
Other putative virulence genes such as iss, etsC, ompTp and hlyF were not upregulated in any of the conditions
studied. Transcriptome analysis of the pS88-like plasmid recovered in vivo showed a similar pattern of induction
but at much higher levels.
Conclusion: We identify new pS88 genes potentially involved in the growth of E. coli meningitis strain S88 in
human serum and urine.
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Escherichia coli clone O45:K1:H7, belonging to virulence
sequence type (ST)95, is a major cause of neonatal men-
ingitis and of urosepsis in young infants in France [1,2].
The recently sequenced O45:K1:H7 strain S88, isolated
from cerebrospinal fluid of a neonate, harbors a plasmid
of 134 kb, named pS88, involved in meningeal virulence
and bacteremia [3]. Epidemiological studies have shown
that major genetic determinants of this plasmid are not
restricted to E. coli clone O45:K1:H7 but are widely dis-
tributed among E. coli neonatal meningitis (ECNM)* Correspondence: stephane.bonacorsi@rdb.aphp.fr
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reproduction in any medium, provided the orclones, uropathogenic E. coli strains (UPEC), and avian
pathogenic E. coli strains (APEC) [3-6]. Sequencing of
pS88 revealed 157 ORFs, including genes involved in the
plasmid machinery (transfer, maintenance and replica-
tion), IS-like genes, two colicins (colicin Ia and microcin
V), and several virulence genes of known or putative
functions, such iron-uptake system. These iron-uptake
systems include aerobactin (iucABCD and iutA), salmo-
chelin (iroBCDEN) and the SitABCD transport system
[7-9]. The S88 plasmid also contains the serum survival
gene iss [10,11], the etsABC genes, encoding a putative
type 1 secretion system [4], ompTp, encoding a putative
outer-membrane protease differing from the E. coli
chromosomal ompT gene [12] and hlyF, encoding a
hemolysin [13]. Finally, 35 ORFs have unknown func-
tions and may represent new virulence genes.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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human extraintestinal E. coli (ExPEC) strains responsible
for urinary tract infection [14-17]. To further unravel
the role of pS88 in the virulence of clone O45:K1:H7, we
analyzed the transcriptional response of plasmid pS88
to growth in urine and serum, representing two steps
required for meningeal invasion [18-21]. We also ana-
lyzed the transcriptome of a pS88-like plasmid recovered
from a neonate with urinary tract infection (UTI).
Results and discussion
Validation of transcriptional analysis
The transcriptional analysis was validated first by qRT-
PCR amplification of transcripts of 5 genes (2 house-
keeping genes and 3 plasmidic genes) in serial dilutions
of RNA extracted from S88 grown in LB broth. The Ct
values showed a linear relation with the template dilu-
tion (Figure 1A). Similar results were obtained after
growth in LB broth containing the iron chelator 2,2’-
dipyridyl (data not shown). We also conduced three
independent biological replicates of pS88 after growth in
LB Broth, named experiments 1, 2 and 3, to compare







































Figure 1 Linearity and reproducibility of transcriptional analysis. (A) Q
(B) Analysis of fold changes in RNA transcript abundance by the 2-ΔΔCT me
growth in LB broth (experiment 1 vs 2: dots, experiment 1 vs 3: squares, ex
0.25-4.00 in 98% of cases.fold changes were close to 1, and 98% of values were be-
tween 0.25 and 4 (Figure 1B). Therefore, we considered
that an ORF was upregulated or downregulated if the
change in expression was smaller or larger than 0.25-fold
and 4-fold, respectively, with p values ≤0.05. These thresh-
olds are in line with those selected by Mobley et al. [16].
Global analysis of the pS88 transcriptome ex vivo and
the pAMM transcriptome in vivo
Table 1 shows the transcriptome patterns for pS88
grown in iron-depleted LB, in human urine and serum,
as well as that of pAMM (recovered from human urine
in vivo). A transcript was detected for all 88 ORFs
tested, except for ORF 23. Overall, 18 ORFs (19%), 10 of
which corresponded to 5 operons, were upregulated in
at least one of the three ex vivo conditions. The only
down-regulated genes were traA in urine, and ydfA and
ORF 132 in iron-depleted LB broth. The transcriptome
pattern of pAMM largely matched the ex vivo patterns,
indicating that growth in human urine ex vivo was a
relevant model. Interestingly, the fold changes observed
in vivo were far higher than those observed ex vivo







uantitative RT-PCR of 5 ORFs using different RNA concentrations.
thod across 3 biological replicates named experiments 1, 2 and 3 after
periment 2 vs 3: triangles). The fold changes fall within the range
Table 1 Transcriptional expression of pS88 and pAMM ORFs in different growth conditions compared to LB broth








pS88001 int Putative site-specific recombinase 0.85 0.775 0.59 0.427 0.73 0.505 0.84
pS88002 repA RepFIB replication protein RepA 0.41 0.305 0.97 0.976 0.89 0.889 3.56
pS88003 Conserved hypothetical protein 1.67 0.496 1.26 0.758 3.09 0.159 7.26
pS88004 Conserved hypothetical protein 0.93 0.883 0.58 0.266 0.60 0.459 2.52
pS88006 Putative fragment of ImpB UV
protection protein
0.48 0.578 0.77 0.550 1.51 0.367 1.17
pS88009 iutA Ferric aerobactin receptor precursor IutA 4.12 0.007 4.23 0.006 4.01 0.048 9.02
pS88013 iucA Aerobactin siderophore biosynthesis
protein IucA
45.25 0.005 15.85 0.023 18.38 0.026 168.12
pS88014 shiF Putative membrane transport protein ShiF 7.66 0.006 14.03 0.005 14.19 0.004 17.71
pS88015 Putative membrane protein; CrcB-like
protein
2.40 0.105 0.82 0.807 4.19 0.051 6.08
pS88016 Conserved hypothetical protein 1.77 0.250 1.65 0.628 4.14 0.066 9.74
pS88017 Putative enolase 1.47 0.573 5.44 0.152 7.98 0.040 18.68
pS88019 sitD SitD protein; iron transport protein 4.54 0.020 38.23 0.003 26.29 0.004 139.75
pS88022 sitA SitA protein; iron transport protein 17.79 0.002 49.52 0.003 83.87 0.001 776.05
pS88026 Hypothetical protein 1.32 0.633 1.04 0.959 1.02 0.981 /c
pS88027 Hypothetical protein; putative
exported protein
0.70 0.626 1.04 0.956 0.31 0.187 /
pS88028 Conserved hypothetical protein 1.11 0.809 0.75 0.577 1.16 0.762 /
pS88029 Conserved hypothetical protein 1.30 0.712 1.22 0.751 2.20 0.260 /
pS88030 Conserved hypothetical protein 0.30 0.098 0.46 0.308 0.32 0.143 1.09
pS88031 Hypothetical protein 0.67 0.405 0.97 0.959 1.58 0.369 2.08
pS88037 sopA SopA protein (Plasmid partition
protein A)
0.60 0.227 0.47 0.147 1.12 0.847 0.98
pS88038 sopB SopB protein (Plasmid partition
protein B)
0.38 0.021 0.91 0.879 1.41 0.696 3.32
pS88039 Hypothetical protein 0.63 0.312 2.19 0.330 3.82 0.031 2.96
pS88040 Conserved hypothetical protein 0.73 0.510 2.74 0.240 3.61 0.031 3.61
pS88041 Hypothetical protein 1.39 0.295 0.42 0.174 1.77 0.092 1.47
pS88043 Hypothetical protein 0.89 0.782 1.47 0.378 2.00 0.188 1.83
pS88044 yubI Putative antirestriction protein 1.35 0.720 1.13 0.890 0.99 0.991 3.38
pS88045 Conserved hypothetical protein 0.95 0.919 1.66 0.403 1.09 0.873 4.52
pS88046 Conserved hypothetical protein 0.80 0.717 1.38 0.661 1.25 0.735 2.07
pS88047 ydbA Conserved hypothetical protein 1.71 0.542 0.99 0.987 1.33 0.739 4.18
pS88048 ydcA Putative adenine-specific DNA methylase 1.44 0.652 1.09 0.917 1.52 0.606 3.98
pS88050 ssb Single-stranded DNA-binding protein 1.56 0.383 2.42 0.152 1.96 0.211 2.91
pS88051 yubL Conserved hypothetical protein 0.90 0.832 1.21 0.842 2.13 0.203 2.05
pS88054 ycjA Putative DNA-binding protein involved
in plasmid partitioning (ParB-like
partition protein)
1.31 0.260 2.60 0.392 3.45 0.007 2.30
pS88055 psiB Plasmid SOS inhibition protein B 0.74 0.414 5.34 0.094 3.26 0.026 4.03
pS88056 psiA Plasmid SOS inhibition protein A 1.67 0.321 13.06 0.048 6.44 0.016 3.02
pS88057 flmC Putative F-plasmid maintenance
protein C
2.27 0.144 0.55 0.346 0.65 0.401 2.21
pS88059 yubN Conserved hypothetical protein 2.01 0.441 0.90 0.902 1.20 0.826 3.52
pS88060 yubO Conserved hypothetical protein 1.13 0.781 1.79 0.211 2.24 0.075 3.89
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(Continued)
pS88061 yubP Conserved hypothetical protein 1.43 0.397 2.40 0.109 1.72 0.408 4.27
pS88062 yubQ X polypeptide (P19 protein); Putative
transglycosylase
0.94 0.948 0.88 0.910 1.20 0.852 4.90
pS88063 traM Protein TraM (Conjugal transfer protein M) 0.77 0.313 0.94 0.866 0.92 0.769 0.25
pS88064 traJ Protein TraJ (Positive regulator of conjugal
transfer operon)
0.39 0.212 2.86 0.310 1.08 0.898 1.98
pS88066 traA Fimbrial protein precursor TraA (Pilin) 1.59 0.053 0.54 0.188 0.19 0.004 0.21
pS88092 traT Complement resistance and surface
exclusion outer membrane protein TraT
0.27 0.265 0.54 0.573 0.82 0.847 0.35
pS88095 traX F pilin acetylase TraX 0.56 0.157 0.54 0.409 0.72 0.389 0.88
pS88096 finO Fertility inhibition protein FinO
(Conjugal transfer repressor)
0.49 0.127 0.98 0.968 0.88 0.732 1.21
pS88097 yigA Conserved hypothetical protein YigA 1.22 0.803 2.08 0.427 0.95 0.953 0.50
pS88098 yigB Putative nuclease YigB 0.46 0.241 0.47 0.463 1.34 0.648 2.34
pS88099 repA2 Replication regulatory protein RepA2
(Protein CopB)
1.27 0.340 1.43 0.199 2.24 0.071 1.93
pS88100 repA1 Replication initiation protein RepA1 0.56 0.120 1.14 0.702 2.18 0.072 1.53
pS88101 yacA Conserved hypothetical protein YacA.
possible repressor
0.49 0.344 0.96 0.961 0.41 0.293 4.30
pS88102 yacB Putative plasmid stabilization system
protein YacB
0.31 0.169 0.64 0.502 0.32 0.227 1.57
pS88103 yacC Putative exoribonuclease YacC 0.38 0.209 0.56 0.461 0.50 0.369 0.95
pS88104 cia Colicin-Ia 5.11 0.105 21.06 0.023 6.03 0.087 70.36
pS88105 imm Colicin-Ia immunity protein 1.10 0.944 5.58 0.048 3.46 0.106 3.17
pS88106 ybaA Conserved hypothetical protein YbaA 5.25 0.197 4.87 0.189 8.90 0.096 3.27
pS88108 ydeA Conserved hypothetical protein YdeA 0.45 0.247 0.31 0.165 0.41 0.222 0.51
pS88109 ydfA Conserved hypothetical protein YdfA 0.17 0.119 0.69 0.733 0.36 0.284 0.58
pS88110 Putative acetyltransferase 0.71 0.606 0.98 0.983 0.77 0.684 1.57
pS88111 Predicted dehydrogenase 1.41 0.562 0.31 0.126 0.88 0.801 1.48
pS88112 Predicted dehydrogenase 1.25 0.691 0.63 0.416 1.19 0.736 0.87
pS88113 Predicted dehydrogenase 0.92 0.893 1.13 0.850 1.65 0.509 3.02
pS88114 cvi Microcin V immunity protein 0.84 0.735 1.13 0.846 2.17 0.203 4.48
pS88115 cvaC Microcin V precursor (Microcin V
bacteriocin)
21.96 0.007 17.27 0.010 29.58 0.016 61.11
pS88116 cvaB Microcin V secretion/processing
ATP-binding
protein CvaB
12.88 0.010 17.55 0.001 19.43 0.006 162.02
pS88117 cvaA Microcin V secretion protein CvaA 26.23 0.012 44.02 0.005 43.81 0.019 215.77
pS88118 Conserved hypothetical protein 3.99 0.095 4.66 0.066 3.32 0.219 7.46
pS88123 Putative Phospho-2-dehydro-3-
deoxyheptonatealdolase
354.6 0.000 190.9 0.001 109.6 0.006 144.67
pS88124 iroN IroN. Salmochelin siderophore receptor 2.94 0.137 2.14 0.465 1.95 0.394 28.97
pS88128 iroB IroB. Putative glucosyltransferase 72.17 0.001 48.95 0.002 37.97 0.014 69.71
pS88130 Conserved hypothetical protein 1.84 0.336 3.36 0.198 10.36 0.029 3.10
pS88131 Conserved hypothetical protein 2.43 0.318 9.11 0.031 13.83 0.039 14.66
pS88132 Hypothetical protein 0.20 0.013 0.95 0.871 0.63 0.482 0.40
pS88133 iss Iss (Increased serum survival) 0.28 0.083 0.48 0.282 0.36 0.151 0.66
pS88136 Hypothetical protein 0.93 0.896 1.51 0.618 1.71 0.391 0.65
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pS88137 Conserved hypothetical protein;
Putative GTPase
0.40 0.263 0.52 0.504 0.64 0.580 1.59
pS88142 Conserved hypothetical protein 0.51 0.096 0.48 0.134 0.77 0.458 /
pS88143 Conserved hypothetical protein 0.57 0.090 0.70 0.646 0.84 0.750 /
pS88146 etsC Putative type I secretion outer
membrane
protein EtsC
1.05 0.893 0.42 0.208 0.78 0.478 0.61
pS88148 etsA Putative type I secretion membrane-
fusion
protein EtsA
0.49 0.126 0.34 0.211 0.36 0.050 0.31
pS88154 Hypothetical protein 0.47 0.330 4.44 0.163 1.25 0.790 3.00
pS88155 ompT Outer membrane protease (omptin) 0.48 0.178 0.43 0.092 0.42 0.137 0.37
pS88156 hlyF Hemolysin HlyF 1.02 0.981 0.44 0.402 0.72 0.507 0.14
pS88157 Conserved hypothetical protein;
putative Mig-14 protein
1.11 0.921 0.47 0.376 0.94 0.942 0.11
S88-1832 gapAd Glyceraldehyde-3-phosphate
dehydrogenase
1.70 0.396 0.46 0.254 1.15 0.789 0.90
S88-0266 dinBd DNA polymerase IV 0.69 0.343 2.36 0.131 0.69 0.317 0.90
S88-4457 yjaDd NADH pyrophophatase 0.85 0.586 0.91 0.698 1.26 0.344 1.24
a Fold changes of transcription levels relative to reference condition (growth in LB). Fold change> 4 are in bold print.
b p value in Student’s t test for the comparison of the three biological replicates for each experiment in different growth conditions and the reference condition.
p < 0.05 are in bold print.
c ORFs present in plasmid pS88 but absent from plasmid pAMM. d Housekeeping genes.
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The concentration of free iron in human urine and
serum is low, because iron is sequestered by host mole-
cules [22-24]. E. coli has developed several strategies to
acquire iron in such environments. Ten ORFs were
upregulated after growth in urine, in serum, and in iron-
depleted LB, suggesting they were induced by the low
iron concentrations in these media. Five of these 10
ORFs corresponded to iron-uptake and iron-assimilation
systems, namely iutA and iucA (aerobactin), iroB (salmo-
chelin) and sitA and sitB (SitABCD iron transport
system). These iron-uptake systems have previously been
linked to the virulence of ExPEC and APEC [4,7-9,24-27].
Mobley et al. also observed upregulation of UPEC iron-
acquisition systems such as aerobactin, salmochelin and
the SitABCD system in urinary isolates from experimen-
tally infected mice and from women with UTI [14,16].
Likewise, Li et al. found that genes involved in iron acqui-
sition were among the most significantly upregulated
genes during growth in chicken serum of the APEC strain
O1 [28], which harbours a plasmid (pAPEC-O1-ColBM)
closely related to pS88 [3]. Our study represents the first
transcriptional analysis of an E. coli plasmid after growth
in human serum.
Surprisingly, we found that the salmochelin receptor
iroN was not upregulated in our ex vivo experiments,
and that the transcript level of the aerobactin receptor
iutA was markedly lower than that of the siderophoreiucA. In contrast the salmochelin receptor iroN was
upregulated 28-fold in the isolate from a neonate with
UTI. Such discrepancies have been previously described.
In the murine UTI model used by Mobley et al. [16],
iroN was upregulated but its transcript level was also
lower than that of iroB. Moreover, in their transcriptome
analysis of E. coli isolates from eight women with urinary
tract infection, iroN and iutA were only upregulated in
two isolates [14].Colicin expression
Another group of genes upregulated in iron-deficient
conditions were the genes encoding the Microcin V
(cvaA, cvaB, cvaC) and Colicin Ia, which were also upre-
gulated in human serum and urine. Previous reports
have shown the influence of bacterial intracellular iron
levels on colicin expression, but the reason of such
induction is still poorly understood [29-31]. Of note,
transcription of immunity protein for both colicins was
not upregulated in any of the conditions studied except
for Colicin Ia in human serum.Expression of ORFs of unknown function in iron-deficient
environments
Two ORFs with unknown functions, shiF and ORF 123,
were upregulated in iron-deficient conditions, with large
fold changes in vivo and ex vivo.
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fold) in the 3 test conditions, and was expressed 3 to 4
times more strongly than the iron acquisition systems. A
nucleotide homology search using the BLAST program
[32] showed that ORF 123 is highly homologous (99%)
to an ORF present in E. coli plasmids possessing a CVP
region (such pAPEC-O1-ColI-BM, pAPEC-O2-ColV
and pAPEC-1) or located on the chromosome of
UPEC strains such as CFT073 (ORF c1220; 94%) and
536 (ORF ECP–0281; 95%). No homologous gene is
found in the commensal E. coli strain MG1655. Tran-
scriptome analysis by Mobley et al. [16] showed over-
expression of c1220 transcripts in E. coli CFT073 in a
mouse model of UTI. The putative protein encoded by
ORF 123 showed 45-50% identity to three phospho-2-
dehydro-3-deoxyheptonate aldolases that catalyze the
first reaction of the shikimate pathway and are present
on the chromosome of E. coli K12. This pathway
involves seven enzymatic reactions that generate choris-
mate, a factor involved in the synthesis of three aromatic
amino acids (tyrosine, tryptophan and phenylalanine)
[33]. However, this pathway is also involved in other
reactions, such as biosynthesis of siderophore group
nonribosomal peptides such as yersiniabactin and enter-
obactin. In plasmid pS88, as in other CVP-containing
plasmids, ORF 123 lies just upstream of iroN and is pre-
ceded by a sequence resembling the Fur Box consen-
sus sequence (5'-GATAATGATAATCATTATC) [34,35].
BLAST analysis of complete genomes available on pub-
licly available database showed that ORF 123 is only
found when the salmochelin operon is present but the
reciprocity is not true, as for example in strain UTI89,
which harbors only an iro locus. On the chromosome of
E. coli strains CFT073 and 536, this ORF (c1220 and
ECP_0281, respectively) is located in a pathogenicity is-
land containing an iro locus but is 20–30 kb distant from
the iro locus. Because of its putative function, its high
inducibility in iron-depleted conditions, and its physical
proximity to the iro locus, we suspected that this ORF
might be an auxiliary gene that boosts the synthesis of
iron acquisition systems such as salmochelin by enhan-
cing the production of chorismate and, consequently,
enterobactin, the precursor of salmochelin [36].
The shiF ORF was also upregulated in iron-deficient
environments. ShiF was first described in the pathogen-
icity island SHI-2 in Shigella flexneri [37] and encodes a
putative protein belonging to the major facilitator super-
family. The latter is one of the two largest families of
membrane transporters capable of transporting small
solutes in response to chemiosmotic ion gradients. Tran-
scriptome analysis of APEC O1 grown in chicken serum
showed that shiF was also upregulated [28]. BLAST ana-
lysis revealed that shiF is present in many UPEC and
APEC strains, but only when the locus encodingaerobactin is present, although the two do not always
colocalize. Of interest, in pS88, as in Shi-2, shiF is
located just upstream of the aerobactin operon, on the
opposite strand, and shares the same Fur Box. These
results suggest that shiF induction is at least partly regu-
lated by iron deficiency and that, like ORF 123, shiF may
be an auxiliary gene that promotes the transport of ly-
sine, the precursor of aerobactin.
Specific ORF expression in serum and urine
A minority of ORFs were upregulated in serum and/or
urine but not in iron-depleted LB broth. Two of these
ORFs were upregulated only in urine (ORFs 17 and
130), while 2 ORFs were upregulated in both serum and
urine (psiA and ORF 131). Meanwhile the putative role
of ORF 130, ORF 131 and psiA in the steps studied
could not be predicted, the most strongly upregulated
ORF in urine, ORF 17, could play a role in the infection
process. This ORF codes for a putative enolase, an en-
zyme involved in the penultimate step of glycolysis and
that catalyses 2-phosphoglycerate conversion to phos-
phoenolpyruvate. Intriguingly this latter molecule is the
substrate of the phospho-2-dehydro-3-deoxyheptonate
aldolase involved in the shikimate pathway. ORF 17
might therefore help to optimize the synthesis of iron-
uptake systems in urine.
Other putative virulence genes
Other putative virulence factors like ompTp, etsC, iss
and hlyF [10-13,38,39] were not upregulated in any of
the conditions studied here. Nolan et al. has reported
upregulation of the etsABC genes (but not iss) in APEC
O1 strains, including pAPEC-O1-ColBM, grown in
chicken serum at 37°C [28]. In contrast, in their tran-
scriptional analysis of 8 genes in pAPEC-O2-ColV grown
in chicken serum and human urine, they found that iss,
but not etsC, was upregulated in chicken serum [40].
Moreover, hlyF was also upregulated in chicken serum
but not in human urine. Variability between commercial
chicken serum could explain the observed differences in
the previously mentioned studies. Alternatively, these
putative virulence genes may be induced in highly spe-
cific conditions that remain to be determined.
Conclusion
While several studies have examined E. coli virulence
gene expression in animal models, little is known about
their expression during human infection [14,15]. Here
we identified several genes that may play a key role dur-
ing E. coli growth in human serum and urine. Further
studies are necessary to determine the roles of these
candidate virulence genes and to understand the contri-
bution of plasmid pS88 to the virulence of E. coli strain
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E. coli meningitis strain S88, representative of the French
clonal group O45:K1:H7, has been shown to harbor a
virulence plasmid of 134 kb, designated pS88 [3]. E. coli
strains responsible for UTI in young infants were
screened for transcriptional analysis in vivo, as follows.
The O45-specific genes and K1 capsular antigen were
detected as described elsewhere [41,42]. The presence of
iss, etscC, hlyF, ompTp and cvaA, together with the genes
encoding salmochelin (iroN), aerobactin (iucC) and the
iron-uptake system SitABCD (sitA), considered to be a
signature of a conserved virulence plasmidic (CVP) re-
gion characteristic of pS88 [38], were sought by PCR as
previously described [3].
Growth conditions
An overnight culture of strain S88 in Luria Bertani (LB)
broth (Sigma) was diluted 1/100 in LB broth and grown
at 37°C with agitation until optical density at 600 nm
(OD600) reached 0.65. This culture represented the refer-
ence condition for this study. Strain S88 was also grown
in LB broth containing the iron chelator 2,2’-dipyridyl
(Sigma, Saint Quentin Fallavier, France) at a final con-
centration of 200 μM, as previously described [43]. With
their informed consent, serum was collected at Etablisse-
ment Français du Sang from healthy blood donors aged
from 20 to 40 years who had no history of infection or
antibiotic use in the previous 2 months. Serums from 20
donors were pooled and aliquots of 500 μl were stored
at −80°C until use. Transcriptome analysis of E. coli cul-
tured in serum was performed as follows: an overnight
culture of S88 in LB broth was diluted 1/10 in physio-
logical saline, then 250 μl of this dilution was mixed with
250 μl of serum and incubated at 37°C for 3 hours; the
culture was centrifuged for 7 min at 9000 g and 21°C in
a microcentrifuge (Jouan) and the pellet was resus-
pended in 500 μl of physiological saline. RNA was im-
mediately stabilized with RNA Protect Bacterial Reagent
(QIAGEN) and the sample was stored at −20°C until
RNA extraction. With their parents’ informed consent,
sterile urine was collected from healthy children aged
from 3 months to 5 years who had no history of UTI or
antibiotic use in the previous 2 months, and was stored
in aliquots of 5 ml at −20°C. An overnight culture of S88
in LB broth was diluted 1/100 in the pooled urine and
cultured at 37°C until OD600 reached 0.25 (preliminary
experiments showed that this represented the mid-
exponential phase of growth in urine). RNA was then
stabilized as described above. To analyze the regulation
of pS88 expression in vivo, aliquots of fresh urine wereobtained from children aged no more than 3 months
who had been admitted to Robert-Debré Hospital for
fever and whose urine contained ≥ 106 leukocytes per ml
and numerous Gram-negative rods. The samples were
immediately treated with RNA Protect Bacterial Reagent
(QIAGEN) and stored at −20°C until RNA extraction. If
urine culture yielded ≥105 E. coli CFU/ml and no other
bacteria, confirming the diagnosis of UTI, the serotype
was determined and genes characteristic of the CVP re-
gion were sought as described above. Among the 10 iso-
lates analyzed, one, designated AMM, was recovered in
2010 from urine of a 2-month-old infant with acute
pyelonephritis and no medical history. This strain,
belonged to ST95, was of serogroup O45:K1 and har-
bored the main chromosomal virulence genes (fuyA,
papC, papGII) and the CVP region, indicating that
AMM belongs to the O45:K1 clonal group and is very
similar to S88. PCRs specific for 88 plasmidic ORFs of
interest (see below) showed that the pAMM plasmid
possessed 82 of these ORFs. RNA was extracted as
described above, directly from urine stored at −20°C, and
after growth in LB (reference condition).
RNA extraction
RNA from ex vivo and in vivo samples was extracted
with the RNeasy Mini kit (QIAGEN) according to the
manufacturer’s instructions. Total RNA was then iso-
lated with the RNase-Free DNase set (QIAGEN). The
concentration of total RNA was determined with ND-
1000 spectrophotometer (NanoDrop) and adjusted to a
final concentration of 0.05 μg/μl.
Quantitative reverse transcription-PCR (qRT-PCR)
For transcriptome analysis, all ORFs of unknown func-
tion and between 1 and 4 ORFs with known functions at
each plasmid locus except most genes corresponding to
plasmid transfer systems, insertion sequences and trans-
posases were chosen. A total of 88 plasmid transcripts
were retained for investigation. As previously recom-
mended [44], three housekeeping genes were used for
normalization, chosen among previously described genes
(gapA, dinB and yjaD) [16,45]. Primers were designed
with Primer 3 software [46]. Assays were performed in
microplates (Eurogentec), the primer pairs being distrib-
uted directly at a concentration of 200 nM with a Euro-
gentec device. Reverse transcriptase (EuroScript RT,
0.125 U/μl) and RNA extract (0.05 μg/μl) were added to
the One-step MESA GREEN qRT-PCR MasterMix Plus
for SYBR assay (Eurogentec) according to the manufac-
turer’s instructions, and the mix was distributed in the
microplates (0.05 μg of RNA in each final reaction mix).
Reverse transcription and amplification were performed
with an LC480 Light Cycler (Roche) in one step with the
following cycling parameters: 30 min at 48°C for reverse
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inactivation and Taq activation, and 45 cycles of 15 s
at 95°C, 20 s at 60°C and 40 s at 72°C. Melting curve
analysis of each reaction product was used to control
the specificity of qRT-PCR.
Data and statistical analysis
The cycle threshold (Ct) was automatically determined
by using the Second Derivative Maximum Method
included in LC480 software. The Ct values provided by
the qRT-PCR instrument were imported into a spread-
sheet program (Microsoft Excel). The fold change in the
abundance of the 88 ORF transcripts between each test
condition (growth in LB with 2,2’-dipyridyl, serum and
urine) and the reference condition (growth in LB) was
calculated by using the 2-ΔΔCT method [47,48]. The aver-
age of 3 housekeeping genes (gapA, dinB, yjaD) was
used for the normalization [44]. Briefly, the first ΔCt
represents the difference of Ct between the investigated
gene and the average of the 3 housekeeping genes and
the ΔΔCt is then calculated using the formula
ΔΔCt=ΔCt(test condition)- ΔCt(reference condition).
For transcriptome analysis during growth in vitro and
ex vivo, three independent experiments (biological and
technical replicates) were performed in each condition,
including growth, RNA extraction and qRT-PCR. The
in vivo experiment was performed only once because of
the limited available amount of urine.
A p value for each ORF was calculated by using
Student’s t test to compare the three replicates for each
bacterial growth condition.
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